{"disease":{"id":"infections-respiratory-syncytial-virus","name":"infections respiratory syncytial virus"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07358910","title":"Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Institut Pasteur du Cambodge","has_results":false},{"nct_id":"NCT00246480","title":"RSV Disease in the Elderly","phase":"","overall_status":"COMPLETED","enrollment_count":1401,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT04925310","title":"Infection With Respiratory Syncytial Virus in Infants","phase":"","overall_status":"UNKNOWN","enrollment_count":350,"lead_sponsor_name":"Hannover Medical School","has_results":false},{"nct_id":"NCT01905215","title":"Study to Evaluate the Safety, Reactogenicity and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Investigational Respiratory Syncytial Virus (RSV) Vaccines","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":128,"lead_sponsor_name":"GlaxoSmithKline","has_results":false},{"nct_id":"NCT06216093","title":"Phase I, First-In Human Study to Evaluate Safety and Tolerability of EuRSV in Healthy Adults Aged Between 19 Years and 80 Years","phase":"PHASE1","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":100,"lead_sponsor_name":"EuBiologics Co.,Ltd","has_results":false},{"nct_id":"NCT01502072","title":"Respiratory Syncytial Virus - RSV Protocol","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":48,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":true},{"nct_id":"NCT02201303","title":"Evaluation of Danirixin (GSK1325756) Inhibition of CD11b Cell Surface Expression","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"GlaxoSmithKline","has_results":false},{"nct_id":"NCT03757429","title":"Inflammatory Mediators Associated With Infection by Respiratory Syncytial Virus","phase":"","overall_status":"COMPLETED","enrollment_count":31,"lead_sponsor_name":"Uppsala University","has_results":false}],"total":8},"guidelines":[],"source":"Drug Landscape verified database"}